cytotect cp biotest 100 u/ml otopina za infuziju
biotest pharma gmbh, landsteinerstr. 5, dreieich, njemačka - imunoglobulin protiv citomegalovirusa, людски - otopina za infuziju - 100 u/ml - urbroj: jedan ml otopine za infuziju sadrži: protein ljudske plazme 50 mg (od toga najmanje 96% imunoglobulin g), sa sadržajem antitijela protiv citomegalovirusa (cmv) od 100 u
heplisav b
dynavax gmbh - hepatitis b površinski antigen - hepatitis b - cjepiva - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.
anidulafungin fresenius kabi 100 mg prašak za koncentrat za otopinu za infuziju
fresenius kabi d.o.o., radnička cesta 37a, zagreb, hrvatska - anidulafungin - prašak za koncentrat za otopinu za infuziju - 100 mg - urbroj: jedna bočica sadrži 100 mg anidulafungina.
zelboraf (▼) 240 mg/1 tableta film tableta
roche d.o.o.roche ltd. - vemurafenib - film tableta - 240 mg/1 tableta - 1 film tableta sadrži: 240 mg vemurafenib
cotellic (▼) 20 mg/1 tableta film tableta
roche d.o.o.roche ltd. - kobimetinib - film tableta - 20 mg/1 tableta - 1 film tableta sadrži: 20 mg kobimetiniba u obliku kobimetinib hemifumarata
oxlumo
alnylam netherlands b.v. - lumasiran sodium - hyperoxaluria, primary - drugi gastrointestinalni trakt i metabolizam, lijekovi, - treatment of primary hyperoxaluria type 1 (ph1) in all age groups.
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - cjepiva - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - agenti imaju antikancerogena - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
zutectra
biotest pharma gmbh - human hepatitis b immunoglobulin - immunization, passive; hepatitis b; liver transplantation - imuni serumi i homologna, - prevencija ponovne infekcije virusom hepatitisa b (hbv) u negativnim bolesnicima odraslih osoba hbsag i hbv-dna najmanje jedan tjedan nakon transplantacije jetre zbog hepatitisa b induciranog zatajivanja jetre. negativni status hbv-dna trebao bi se potvrditi u posljednja 3 mjeseca prije olt-a. bolesnici trebaju biti hbsag negativni prije početka liječenja. uz primjenu odgovarajućih agenata виростатического treba promatrati kao standard hepatitisa ponovno zaraze prevencija.
ampivet prašak s vitaminima
genera d.d., kalinovica, rakov potok, hrvatska - ampicilin, retinol (vit. a), kolekalciferol (vit. d3), nikotinamid (vit.b3), askorbinska kiselina (vit. c), kalcijev pantotenat (vit. b5), tokoferolacetat (vit. e), tiamin klorid (vit. b1), piridoksin klorid (vit. b6), riboflavin-5-fosfat-natrij (vit. b2), cijanokobalamin (vit. b12), menadion-natrij hidrogensulfit (vit. k3), metionin, natrijev sulfat, željezo, mangan, cink, bakar. - prašak za peroralnu otopinu - teladi, prasadi, janjadi, jaradi i peradi čija se jaja ne koriste za prehranu